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Plasmids harboring antibiotic resistance genes differ in their kinetic values as plasmid 21 
conjugation rate,  segregation rate by incompatibility with related plasmids, rate of  22 
stochastic loss during replication, cost reducing the host-cell fitness, and frequency of 23 
compensatory mutations to reduce plasmid cost, depending on the cell mutation 24 
frequency. How variation in these values influence the success of a plasmid and their 25 
resistance genes in complex ecosystems, as the microbiota? Genes are located in 26 
plasmids, plasmids in cells, cells in populations. These populations are embedded in 27 
ensembles of species in different human hosts, are able to exchange between them 28 
bacterial ensembles during cross-infection and are located in the hospital or the 29 
community setting, under various levels of antibiotic exposure. Simulations using new 30 
membrane computing methods help predict the influence of plasmid kinetic values on 31 
such multilevel complex system. In our simulation, conjugation frequency needed to be 32 
at least 10-3 to clearly influence the dominance of a strain with a resistant plasmid. Host 33 
strains able to stably maintain two copies of similar plasmids harboring different 34 
resistances, coexistence of these resistances can occur in the population. Plasmid loss 35 
rates of 10-4 or 10-5 or plasmid fitness costs ≥0.06 favor the plasmids located in the most 36 
abundant species. The beneficial effect of compensatory mutations for plasmid fitness 37 
cost is proportional to this cost, only at high mutation frequencies (10-3-10-5). 38 
Membrane computing helps set a multilevel landscape to study the effect of changes in 39 
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Plasmid kinetics are widely assumed to necessarily influence the spread of antibiotic 45 
resistance genes in bacterial populations and ecosystems (1-10). The main parameters 46 
that affect plasmid kinetics are: a) the rate of plasmid conjugation/transfer (the rate at 47 
which a bacterial cell harboring a conjugative plasmid [donor] transfers this plasmid to 48 
a recipient cell; b) the segregation rate due to plasmid incompatibility (considering the 49 
number of plasmid genome copies that are stably maintained in a bacterial cell); c) the 50 
rate of plasmid cost (the reduction imposed by the presence [and transfer] of a plasmid 51 
in the growth rate of the host bacterial cell); d) the rate of plasmid cost compensation 52 
(measuring the effect of mutations reducing plasmid cost); e) the frequency of 53 
mutational events in the plasmid or bacterial genome; and f) the rate of plasmid loss (the 54 
rate at which plasmids are lost during the bacterial replication process). 55 
However, the effects of these changes on the kinetics of plasmid resistance genes among 56 
bacterial populations are necessarily influenced by numerous other factors acting in 57 
actual biological ecosystems, such as the intestinal microbiota. Of these factors, our 58 
previously published studies on modeling by membrane computing (11-13) considered 59 
the following: the ecosystem’s bacterial composition, the density and replication rate of 60 
cells in each species, their mutation frequencies, the content in chromosomal resistance 61 
genes, the selection intensity of resistant organisms due to differing antibiotic exposures, 62 
the elimination of susceptible bacterial populations by antibiotic treatment, the 63 
transmission of resistant bacteria among human hosts in hospital settings under differing 64 
admission-discharge rates, cross-colonization, and exposure to various antibiotics, as 65 
well as the influence of antibiotic resistance in non-hospitalized individuals who 66 
eventually pass through the hospital environment.  67 
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Experimentally investigating the influence of changes in plasmid kinetic parameters is 68 
extremely difficult and perhaps impossible, under real-world conditions. The research 69 
involves a complex, multilevel, multiparametric, and interactive landscape, involving 70 
genes, cells, populations, communities, hosts, and factors that influence transmission 71 
and selection. However, this problem can be approached using novel computational 72 
models integrating within-host and between-host modeling (14,15). Multilevel 73 
membrane computing models can provide an ecosystem-like framework composed of 74 
discrete independent but interactive units mimicking biological ones in a multi-75 
hierarchical landscape of nested entities (e.g., genes inside plasmids, plasmids inside 76 
bacteria, bacteria inside microbiota, microbiota inside hosts, hosts inside the hospital, 77 
and interacting with the community) (12). 78 
Membrane computing is conceptually based on complex biological systems, which are 79 
characterized by structured nested biological entities than can be conceptualized as 80 
separated by “membranes” (16,17). Each genes, plasmids, cells, species, populations, 81 
hosts, and compartments where the host is located (such as the community or hospital) 82 
is surrounded by “computational membranes” forming a multilevel nested structure, that 83 
can be studied by devices such as membrane systems or P systems (12, 13). The P 84 
system applied in this study mimics the complex biological landscapes in the computer 85 
world. In our model, each of the nested “membrane-surrounded entities” can 86 
independently replicate, propagate, become extinct, transfer into other membranes, 87 
exchange informative material according to flexible rules, mutate, and be selected by 88 
external agents (13). This computational model helps simulate the combined effect of 89 
changes in the various parameters, influencing the spread of antibiotic resistance 90 
plasmids. This study explores how changes in these parameters influence the spread of 91 
antibiotic resistance genes located in plasmids, in bacterial populations, and in microbial 92 
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communities composed of different bacterial species, and which are the consequences 93 
of this spread. We also explore how these changes and their effects determine the 94 
frequency of various clones or species that harbor plasmids with antibiotic resistance 95 
genes.  A simplified representation of the elements introduced in the membrane 96 
computing system is presented in Figure S1 (Supplemental Material). 97 
In summary, we present a number of case studies analyzing the influence of changing 98 
plasmid kinetic values on complex hierarchical dynamics of antibiotic resistance in a 99 
simulated hospital setting. Most of the computing experiments referred to in this study 100 
mimics an evolution of 4.5 years (40,000 1-hour steps). To our knowledge, this is the 101 
first study that has addressed the effect of plasmid kinetic parameters in on the structure 102 
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The details and acronyms employed in the model are provided in Materials and 114 
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Influence of plasmid conjugation rates 119 
How to estimate plasmid transfer rates is not a trivial question (18). In this simulation, 120 
conjugation rates are expressed as the proportion of donor-recipient contacts that result 121 
in a random and reciprocal cell-to-cell E. coli-K. pneumoniae plasmid transfer in a 122 
given period. For instance, 10-6 per hour, indicates that 1 in 100,000 contacts or 1 123 
million donor-recipient contacts resulted in random and reciprocal cell-to-cell E. coli-K. 124 
pneumoniae plasmid transfers per hour. Conjugation rates widely differ in different 125 
plasmid-host combinations (19-22) and also is heavily influenced by the abundance and 126 
well-mixing of interacting bacterial populations (23). Our model included 3 conjugation 127 
rates (10-3, 10-6, and 10-9) applicable to plasmids PL1 and PL3, harbored by either E. 128 
coli or K. pneumoniae. The rate of spontaneous plasmid loss (segregation) was 10-5, and 129 
the mutation frequency for plasmid cost compensatory mutations was 10-5 (mutants 130 
reduced to one half the cost of harboring plasmids). Other default values are as 131 
described in the Materials and Methods section. The results for the various E. coli 132 
phenotypes emerging from the plasmid transfer and mutational resistance to 133 
fluoroquinolones are presented in Figure 1. At first sight, a dramatic effect on the E. coli 134 
population structure is only observed at high plasmid transfer rates (10-3) (Fig. 1a, 1b). 135 
A first selective burst of AbAR (red line) is followed by the AbAR-AbFR phenotype 136 
(brown) (due to the mutational evolution to fluoroquinolone resistance of AbAR cells) 137 
and by the acquisition of PL1 (AbAR) by the AbFR cells. The acquisition of PL3 from 138 
K. pneumoniae occurs almost simultaneously (now, AbA*R-AbCR, light blue) and then 139 
from AbFR E. coli (now, AbAR-AbCR-AbA*R, AbFR, dark blue). Subsequently, the 140 
predominant populations are AbFR E. coli harboring PL3 (AbCR-AbA*R, AbFR) 141 
(green).  142 
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K. pneumoniae is critical at the start of the process by providing the plasmid PL3 143 
(AbCR-AbA*R) to E. coli; however, most plasmid transfers occur among the E. coli 144 
bacteria, thereby acquiring most of the antibiotic resistance benefits (Fig. 1c). With 145 
medium to low transfer rates, E. coli populations appear to remain stable and do not 146 
spread significantly in the human host population (lower boxes in Fig. 1a, 1c). 147 
Interestingly, a logarithmic representation (Fig. 1b) reveals remarkable differences at 148 
the 10-6 and 10-9 transfer rates in regard to the population structure. At both 10-6 and 10-9 149 
transfer rates, there is a steady preservation of the fully susceptible E. coli population 150 
(pink), AbFR E. coli (violet) and containing PL1(AbAR) (red), and populations 151 
harboring PL1 (AbAR-AbFR) (brown). At the 10-6 transfer rate, however, a small part 152 
of the E. coli population acquires the PL3 plasmid from K. pneumoniae (and later from 153 
E. coli/PL3), giving rise to a constant increase in the phenotypes AbCR-AbA*R (green), 154 
AbCR-AbA*R-AbFR (olive green), and AbAR-AbCR-AbA*R, AbFR (dark blue).  155 
Even at the 10-9 transfer rate, a few E. coli capture the PL3 plasmid but are unable to 156 
spread AbCR efficiently in the E. coli population. The long-term maintenance of K. 157 
pneumoniae with PL3 (olive green) is only assured at low transfer rates (10-6, 10-9), 158 
impairing the dominance of resistant E. coli populations (Fig. 1d), given that, at high 159 
transfer rates, the E. coli invade the K. pneumoniae cells with plasmid PL1, which 160 
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Figure 1: Influence of plasmid conjugation frequency (10-3, 10-6, 10-9) on the evolution of E. 166 
coli resistance phenotypes in the hospital. Upper left: Ec0, susceptible, no resistance plasmids 167 
(pink line), EcA, PL1-AbAR (red); EcC, PL3-AbAR-AbCR (light fluorescent green), EcF, AbFR 168 
(violet), EcAC, PL1-AbAR plus PL3-AbAR-AbCR, (light blue), EcAF, PL1-AbAR plus AbFR 169 
(brown), EcCF, PL3, AbAR-AbCR plus AbFR (olive green), EcACF, PL1-AbAR plus PL3-170 
AbAR-AbCR plus AbFR (dark blue). Lower left: a logarithmic representation of the same 171 
resistance phenotypes. Upper right: density of the species E. coli (black line), K. pneumoniae 172 
(olive green), ampicillin-R E. faecium (violet), and ampicillin-S E. faecium (blue-green). Lower 173 
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right: detail of the evolution of K. pneumoniae (olive green) and E. faecium.  Numbers in 174 
ordinates are expressed in hecto-cells (one unit=100 cells in the microbiota) 175 
 176 
Influence of plasmid incompatibility 177 
Our model included the term “plasmid incompatibility” to explore the segregation of 178 
replicons sharing similar partitioning (par) loci, thus leading to mutual interference (24). 179 
We examined 2 highly related conjugative plasmids, PL1 and PL3. Conjugative 180 
plasmids typically have a limited number of plasmid copies (a maximum of 1 to 3 per 181 
cell, maximum 10) (25). In fact, there is an incompatibility phenomenon between 182 
replicons: the failure of 2 highly similar co-resident plasmids to be jointly inherited in a 183 
stable manner. This failure is due to the plasmids’ competition for replication factors or 184 
to delayed plasmid replication after the plasmid segregation in daughter cells (26,27). 185 
We examined the effect of cells tolerating only 1 plasmid copy (PL1 or PL3), where any 186 
new incoming plasmid copy (either PL1 or PL3) is rejected or substituted by one of the 187 
resident copies. We also examined the condition where only 2 plasmid copies can 188 
coexist (2 PL1s or 2 PL3s; or 2 PL1 and 2 PL3) and when 3 plasmid copies can coexist 189 
(all 3 PL1 or PL3; or 2 PL1 plus 1 PL3; or 2 PL3 plus 1 PL1). The question is 190 
particularly relevant, given that the presence of plasmid PL1 (AbAR) (originally located 191 
in E. coli) might prevent or influence the acquisition of plasmid PL3 (originally located 192 
in K. pneumoniae) or vice versa. Figure 2 shows the results of the effects of these 193 
maximum plasmid copy numbers in the population structure of E. coli in the hospital 194 
setting. 195 
 196 
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Figure 2. Effect of plasmid incompatibility on the evolution of E. coli antibiotic resistance 200 
phenotypes in the hospital setting. Ec0, susceptible, no resistance plasmids (pink line), EcA, PL-201 
AbAR (red); EcC, PL3-AbAR-AbCR (light fluorescent green), EcF, AbFR (violet) , EcAC, PL1-202 
AbAR plus PL3-AbAR-AbCR, (light blue), EcAF, PL1-AbAR plus AbFR (brown), EcCF, PL3, 203 
AbAR-AbCR plus AbFR (olive green), EcACF, PL1-AbAR plus PL3-AbAR-AbCR plus AbFR 204 
(dark blue). The rate of plasmid cost compensation was fixed at 10-5. Numbers in ordinates are 205 
expressed in hecto-cells (one unit=100 cells in the microbiota) 206 
 207 
.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 




When a single copy of the plasmid replicon is tolerated in the cell (originally the 209 
plasmid-bearing E. coli cells have a copy of PL1), there is a progressive invasion of E. 210 
coli cells by the plasmid PL3 from K. pneumoniae, giving rise to an increase in the 211 
cephalosporin-resistant (and ampicillin-resistant) phenotype EcC (green line). Through 212 
mutation of these cells, the phenotype also includes the fluoroquinolone-resistant 213 
phenotype (olive green), which can also arise with even higher frequency by the 214 
acquisition of PL1 by AbFR cells and then by displacement of PL1 by PL3 (initially in 215 
K. pneumoniae). These cells lose PL1 (AbAR); even if the PL1 plasmid is transferred, it 216 
does not remain in the cell (blue spikes at the bottom curve). With a maximum of 2 or 3 217 
plasmid copies per cell, we can obtain a similar increase in resistant populations 218 
harboring both PL1 and PL3, with or without fluoroquinolone resistance (dark and light 219 
blue, respectively). 220 
 221 
Influence of random plasmid loss.  222 
In the process of cell division, the daughter cell receives at least one plasmid as a result 223 
of random diffusion influenced by multimer resolution systems (28). In our model, 224 
plasmid loss produced plasmid-free cells. The rate of spontaneous plasmid loss remains 225 
controversial (29). Our results (Fig. 3) indicate that at loss (random segregation) rates of 226 
10-3, E. coli populations with plasmid PL1 or PL3 are not maintained beyond 8000 steps 227 
(approximately 2 weeks). At segregation rates of 10-4, the most abundant plasmids (PL1 228 
in E. coli, with AbAR, in red) are maintained. After an initial increase, however, the 229 
plasmid population containing PL3 steadily decreases because of the incompatibility of 230 
PL3 with the dominant PL1 and due to the progressive reduction of K. pneumoniae with 231 
PL3, reducing the flow toward E. coli. Of course, cells with PL3 are more effectively 232 
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selected than those with PL1, but PL1 is comparatively more abundant than PL3 in the 233 
ecosystem; therefore, PL1 is maintained along the 40,000 steps.  234 
 235 
E. coli cells containing plasmid PL3 can slowly increase in number only at 10-5 236 
segregation rates. At 10-6, these cells reach the density of antibiotic-susceptible or PL1 -237 
containing cells. These results suggest that, at high plasmid segregation rates, the 238 
populations harboring the most abundant plasmids in the ecosystem have an advantage 239 
over populations with minority plasmids; however, if the loss of plasmids is relatively 240 
rare (such as 10-6), different plasmids might coexist in the population. Results with a 10-241 
7 plasmid loss did not significantly differ from those of 10-6 (data not shown). 242 
 243 
Figure 3. Influence of plasmid loss rates on the evolution of E. coli resistance phenotypes in the 244 
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hospital environment. Ec0, susceptible, no resistance plasmids (pink line), EcA, PL1-AbAR 245 
(red); EcC, PL3-AbAR-AbCR (light fluorescent green), EcF, AbFR (violet) , EcAC, PL1-AbAR 246 
plus PL3-AbAR-AbCR, (light blue), EcAF, PL1-AbAR plus AbFR (brown), EcCF, PL3, AbAR-247 
AbCR plus AbFR (olive green), EcACF, PL1-AbAR plus PL3-AbAR-AbCR plus AbFR (dark 248 
blue). Compensation rate for plasmid fitness costs was fixed ad 10E-5.  Numbers are expressed 249 
in hecto-cells (one unit=100 cells in the microbiota) 250 
 251 
Influence of plasmid fitness costs 252 
Plasmid fitness costs imposed to the bacterial host are considered a factor that 253 
contribute for the spreading success of a particular plasmid and their genes (30-33). 254 
Several values for PL1 and PL3 plasmid fitness costs were included in the model to 255 
ascertain the effect of hosting these plasmids (or not) on antibiotic resistance and 256 
species composition. For reference, a plasmid fitness cost of 0.06 indicates a 6% 257 
reduced growth rate for the E. coli and K. pneumoniae strains harboring the PL1 or PL3 258 
plasmid). We investigated the influence of these values with “no fitness cost” (fitness 259 
cost = 0). Default values included in this model were as follows: only 2 plasmids can 260 
coexist in a single cell; the rate of spontaneous plasmid loss is 10-5; the mutation rate to 261 
reduce 50% of the plasmid fitness cost is 10-8. The results are presented in Figure 4. 262 
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Figure 4.  Influence of plasmid fitness cost on the evolution of E. coli antibiotic resistance 264 
phenotypes. The graphs in the left column show the effects for each fitness cost (0, 0.06, 0.12, 265 
0.24, and 0.60). The lines indicate the following: Ec0, susceptible, no resistance plasmids (pink 266 
line), On the left part, effects of no fitness cost (0), and 0.06, 0.12, 0.24, and 0.6 fitness costs. 267 
Ec0, susceptible, no resistance plasmids (pink line), EcA, PL1-AbAR (red); EcC, PL3-AbAR-268 
AbCR (light fluorescent green), EcF, AbFR (violet) , EcAC, PL1-AbAR plus PL3-AbAR-AbCR, 269 
(light blue), EcAF, PL1-AbAR plus AbFR (brown), EcCF, PL3, AbAR-AbCR plus AbFR (olive 270 
green), EcACF, PL1-AbAR plus PL3-AbAR-AbCR plus AbFR (dark blue). The graphs in the 271 
right column show the influence of 3 fitness costs (0.0, 0.06, 0.12) on the species distribution in 272 
the simulated ecosystem: E. coli (black line), K. pneumoniae (olive green), ampicillin-R E. 273 
faecium (violet), ampicillin-S E. faecium (blue-green). Numbers in ordinates are expressed in 274 
hecto-cells (one unit=100 cells in the microbiota) 275 
.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted March 29, 2020. ; https://doi.org/10.1101/2020.03.27.012955doi: bioRxiv preprint 
16 
 
Regarding E. coli phenotypes (Fig. 4, left column) the effect of increasing the plasmid 276 
fitness cost was to steadily reduce the number of strains harboring only PL3 (encoding 277 
AbCR) or PL3 and PL1, alone or in combination with PL1 (AbAR) or AbFR (green, 278 
blue, olive green, dark blue lines). Only with a high plasmid fitness cost (0.60) was 279 
there a clear reduction of the predominant populations containing PL1 in the absence 280 
(red line) or presence (brown line) of chromosomal AbFR, probably due to the 281 
maintenance of an effective plasmid transfer. Note that the population with only 282 
chromosomal mutation (not influenced by plasmid fitness cost [AbFR] rises to 283 
dominance (violet line) but tends to decrease slightly, possibly because the reduction in 284 
cell multiplication provides reduced cell densities and therefore encourages the 285 
emergence of an AbFR mutation. 286 
 Differences in plasmid costs, even comparing no cost with 0.06 or 0.12 plasmid costs, 287 
might influence the species structure in the hospital ecosystem. At cost 0, K. 288 
pneumoniae with PL3 (olive green) steadily increases in frequency. K. pneumoniae 289 
originally benefits from the AbAR (including AbA*R) and AbCR phenotype and 290 
progressively acquires fluoroquinolone resistance, surpassing E. coli with PL1, with 291 
only the AbAR phenotype (black). At cost 0.06, the long-term dominance of K. 292 
pneumoniae is strongly reduced, but E. coli also decreases in frequency. With a cost of 293 
0.12, E. faecium (in which PL1 or and PL3 are naturally absent but with a AbAR-AbCR 294 
phenotype [due to AbAR and AbCR chromosomal PBPs, violet]) tends to dominate. 295 
Thus, the cost of harboring a plasmid (decreasing growth rates) might influence the 296 
abundance and diversity of species present in a particular environments. 297 
Effect of changes in mutation frequency for compensation of plasmid fitness costs.  298 
Mutation frequency should influence the emergence of plasmid cost compensatory 299 
mutations. Compensatory mutations in the bacterial chromosome (30,34) and in the 300 
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plasmid (35-38) might reduce the fitness cost of plasmid carriage, thus increasing the 301 
replication rate of the hosting microorganisms and the spread of plasmids. The 302 
emergence of compensatory mutations is certainly driven by the bacterial mutation 303 
frequency, but the effect of mutation might be asymmetrical if it occurs in the 304 
chromosome or plasmid, given that mutated plasmids can horizontally disseminate more 305 
effectively than mutated chromosomes through vertical transmission and given the 306 
presence of several genes that can compensate the cost, which differ among bacterial 307 
hosts (3, 36-43). In our basic model, high overall mutation were expected to influence 308 
not only plasmid cost compensation but also the selection of chromosomal mutants (for 309 
instance, fluoroquinolone-resistant mutants). To separate the two effects in our model 310 
and to detect the effect of compensating for plasmid fitness cost, we increased the 311 
mutation frequencies but maintained the basic mutation frequency (10-8) for AbFR 312 
observed for rifampicin (44) that can be applied for AbFR (45). In this model, fitness 313 
cost was established at 0.06, and the acquisition of a mutation reduces the fitness cost 314 
by a default value of 0.5. At a normal mutation frequency (10-8) or even 10-5 (data not 315 
shown), the effect of different strengths of mutational compensation on the frequency of 316 
plasmid-mediated antibiotic resistance was almost negligible in our model (Fig. 5). 317 
 318 
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Figure 5. Effect of different compensation strengths of plasmid fitness cost. Lines: 0, no 321 
compensation, pink; 0.2 cost compensation, black; 0.5 cost compensation, brown; 0.9 cost 322 
compensation, blue; 1.1 cost compensation, yellow.  Numbers in ordinates are expressed in 323 
hecto-cells (one unit=100 cells in the microbiota) 324 
Figure 6 shows (left column) the effect of the 10-5 mutation frequency, which occurs by 325 
a small increase in E. coli lineages harboring compensated plasmids (olive green and 326 
dark blue lines), which is even more patent at the 10-3 mutation frequency. The reason 327 
for this small effect on E. coli can be explained by observing the overall landscape of 328 
the bacterial species included in the model (Fig. 6, right column); the proportion of 329 
compensated-plasmid-containing K. pneumoniae increases with the mutation frequency, 330 
probably at the expense of E. coli and E. faecium. Note that high mutation rates allow 331 
bacteria with initially low population sizes to cross the mutational threshold to obtain a 332 
beneficial mutation (46). 333 
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Figure 6. The left column shows the influence of different mutation frequencies (10-8, 10-5, and 336 
10-3) compensating plasmid fitness costs in the evolution of E. coli resistance phenotypes. Ec0, 337 
susceptible to no resistance plasmids (pink line), EcA, PL1-AbAR (red); EcC, PL3-AbAR-AbCR 338 
(light fluorescent green), EcF, AbFR (violet) , EcAC, PL1-AbAR plus PL3-AbAR-AbCR, (light 339 
blue), EcAF, PL1-AbAR plus AbFR (brown), EcCF, PL3, AbAR-AbCR plus AbFR (olive green), 340 
EcACF, PL1-AbAR plus PL3-AbAR-AbCR plus AbFR (dark blue). The right column shows the 341 
corresponding effect on the species composition, E. coli (black line), K. pneumoniae (olive 342 
green), E. faecium ampicillin-R (violet), ampicillin-S E. faecium (blue-green). Numbers in 343 
ordinates are expressed in hecto-cells (one unit=100 cells in the microbiota) 344 
 345 
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Effect of changes in mutation frequency on combined fitness: compensation of 346 
plasmid fitness costs and acquisition of fluoroquinolone resistance. 347 
In the natural world, we can consider that different mutation rates might influence 348 
various bacterial functions differently.  For instance, fluoroquinolone resistance 349 
mutations in topoisomerases typically occur at a rate of 10-8, but the frequency of 350 
mutations influencing reductions in plasmid fitness costs might be much higher (e.g., 351 
10-5) (40). In the Figure 7 there is a representation of the evolution in our complex 352 
landscape of the number of cells with plasmid cost compensation with 10-8 or 10-5 353 
fluoroquinolone resistance mutation frequency.  354 
Statistically, cells with emerging mutations resulting in AbFR rarely compensate the 355 
plasmid costs; however, once an AbFR mutation selects an abundant resistant 356 
population (47), there is a higher probability that a mutation will emerge in this 357 
population and reduce the plasmid fitness cost. Figure 7 (up, left clumn) shows the 358 
evolution of the number of cells in our complex landscape with plasmid cost 359 
compensation when the mutation frequency for fluoroquinolone resistance was 10-8 or 360 
10-5. This result indicates that (as stated above), regardless of the mutational frequency 361 
for plasmid cost compensation, the increased survival of fluoroquinolone-resistant cells 362 
in the hospital environment increases the absolute number of plasmid cost 363 
compensatory mutants. In the 2 panels of the first column of Figure 7b this effect is 364 
visible in the higher nosocomial prevalence of E. coli (black line) when AbFR emerges 365 
at a frequency of 10-5. This strong increase in the AbA-AbFR population carrying PL1 366 
(AbA) in E. coli (brown line) when the mutation frequency is 10-5 is depicted in Figures 367 
7 (left column). The increase in cost-compensatory mutations of PL1 in the increased 368 
AbA-AbFR population likely promotes its spread at these mutation frequencies, 369 
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competing with the less frequent plasmid (PL3), resulting in no clear advantage for 370 




Figure 7. Compensation of plasmid fitness costs and frequency for fluoroquinolone mutation. 375 
Upper left: E. coli cells compensated for fitness costs when mutation rates for fluoroquinolone 376 
resistance are 10-8 (black) or 10-5 (brown-violet). Upper right: the effect of these mutation rates 377 
on species distribution (E. coli [black line], K. pneumoniae [olive green], ampicillin-R E. 378 
faecium [violet], ampicillin-S E. faecium [blue-green]. Bottom: evolution of E. coli antibiotic 379 
resistance phenotypes at fluoroquinolone mutation frequencies of 10-5 (left) and 10-8 (right). 380 
Numbers are expressed in hecto-cells (one unit=100 cells in the microbiota) 381 
 382 
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Combined effects of compensation values for plasmid fitness cost and variation in 384 
plasmid fitness cost 385 
Figure 8, left column (experiment with fixed mutation frequency for plasmid fitness 386 
cost compensation of 10-5) shows that the number of plasmid cost-compensated E. coli 387 
is lower when the cost of carrying the plasmid increases (given that bacteria replicate 388 
more slowly); however, cost-compensated bacteria (green line) outpace the non-389 
compensated bacteria (red line) much earlier. Thus, the expected benefit of mutational 390 
compensation is proportional to the fitness cost imposed by the plasmid (37). By 391 
increasing the plasmid fitness cost, the replication of bacteria is impaired, thus possibly 392 
reducing the population size and the possibility of obtaining compensatory mutations. 393 
Consequently, the reduction in plasmid fitness cost by compensatory mutations should 394 
increase population sizes. On the other hand, the benefit of high mutation frequencies in 395 
reducing the plasmid fitness cost should be proportional to this cost. Figure 8 (right 396 
column) shows the outcome for our “hospital scenario” of the E. coli population with a 397 
cost-compensated and a noncompensated plasmidome. For the same level of 398 
compensation (0.2), the rise in compensated cells (green line) is higher for 0.12 than for 399 
0.06 plasmid fitness costs. If we increase the fitness cost compensation level (to 0.5), 400 
the rise in mutated cells is even higher, as expected, because the mutational yield is 401 
proportional to the population size. 402 
 403 
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Figure 8. Effects of plasmid compensation depending on the plasmid fitness cost. In the left 407 
column, no compensated E. coli cells for plasmid fitness cost (green line) versus compensated 408 
cells (red). In the right column, combinations of 2 fitness cost values (0.06 and 0.12) with 2 409 
strengths of compensation values (0.2 and 0.5). Small blue ovals highlight that when the 410 
plasmid cost is higher the compensation is more effective.  Numbers in ordinates are expressed 411 
in hecto-cells (one unit=100 cells in the microbiota) 412 
 Discussion 413 
Plasmid biology should consider the multi-dimensional space where plasmids replicate 414 
and disseminate, not only inside and between bacterial cells, but in complex ecosystems. 415 
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The application of membrane computing models to study the horizontal conjugative 416 
transfer of antibiotic resistance genes in bacteria (ref) is one of the few available 417 
approaches for addressing bacterial evolutionary dynamics in such a broad ecological 418 
context (14). Based on our previously published model  (12), in this study  the influence 419 
of various plasmid kinetic values in the evolution of antimicrobial resistance (8), was 420 
modeled within a complex system resembling the natural conditions that influence 421 
transmission at different levels (e.g., the flow of human hosts in the hospital and 422 
community, bacterial transmission/transfer rates among hosts, bacterial population sizes 423 
in the hosts, exposure and effects of various antibiotics in reducing bacterial numbers, 424 
selection of antibiotic resistant species, and the influence of “space for colonization” of 425 
resistant strains in the microbiota (12). 426 
Details of the basic model’s design have been presented elsewhere (11, 12, 13). These 427 
integrative models are mostly fed with data on plasmid biology obtained through in-428 
vitro experiments and suggest that predictions based only on laboratory data might not 429 
necessarily reflect the evolution of resistance in natural clinical landscapes. This study 430 
presents only a model under particular conditions (see Materials and Methods section), 431 
which were selected as representative examples; however, many other conditions can be 432 
introduced into the parameters in our accessible model 433 
(https://sourceforge.net/projects/ares-simulator/). Our main findings might help explain 434 
the relative weight of parameters that modify plasmid kinetics in the evolution of 435 
antibiotic resistance. 436 
Plasmid transmission rates (the conjugation rates in our model) have been considered 437 
one of the main drivers of the spread of antibiotic resistance genes in natural bacterial 438 
populations (27). In fact, there is a line of research on ecology-evolution (eco-evo) 439 
drugs that seeks to develop plasmid conjugation inhibitors to reduce the burden of 440 
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antibiotic resistance (48, 49). In our complex multilevel system and under the fixed 441 
conditions of the simulation, only high (10-3) conjugation rates clearly influence the 442 
dissemination of plasmids and the resistances they contain. However, we were able to 443 
differentiate between conjugation rates of 10-6 (in which the plasmid PL3 slowly 444 
propagates) from 10-9 (in which effects or transfers are no longer visible). Interestingly, 445 
higher conjugation rates (at which E. coli transfer PL1 [AbAR] effectively) tend to 446 
displace PL3 (AbCR, AbAR) resistance in K. pneumoniae (through par incompatibility). 447 
Thus, the PL3 is only preserved under low conjugation rate conditions in K. 448 
pneumoniae. 449 
Plasmid incompatibility refers to the number of plasmids (replicons) sharing the same 450 
par system (in our case, PL1 and PL3) that can coexist in the same cell. In our 451 
simulation and under conditions allowing only a single plasmid to be maintained, PL3 452 
(containing AbCR-AbAR) from K. pneumoniae can displace PL1 (AbAR); thus, AbCR 453 
significantly increases in E. coli. Conversely, the introduction of PL1 from E. coli into 454 
K. pneumoniae severely reduces the number of K. pneumoniae cells harboring PL3. In 455 
the conditions set in the present simulation (conjugation rate 10-6), if the cell tolerates 2 456 
replicon copies and PL1 + PL3 can coexist, the number of E. coli cells harboring PL3 457 
(AbCR) comparatively decreases, and there are no significant differences if the cell is 458 
able to maintain 3 replicons, a result that might be modified by the conjugation rate. In a 459 
previous published study by our group (12), K. pneumoniae retained PL3 (AbCR) if the 460 
conjugation rate is higher, 10E-4. Note that in the real world, K. pneumoniae frequently 461 
serves to introduce in the ecosystem plasmids with AbCR, that are then transferred to E. 462 
coli, and subsequently among E. coli populations (50, 51).  Because E. coli has a 463 
comparatively higher population size, and most of the conjugations occur at the 464 
intraspecies level, in many cases the AbCR hospital “epidemics” tends to occur at long 465 
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term in E. coli, and AbCR K. pneumoniae is usually maintained at a lower frequency 466 
(52,53,54,55). 467 
Plasmids segregate (disappear, are lost) from the cells in which they are hosted, but the 468 
segregation rates are not well established and depend on the ecological-physiological 469 
conditions of the bacteria and the segregation mechanisms. In our model system, 470 
plasmid loss rates of 10-3 led to plasmid extinction. In general, high segregation rates 471 
favor plasmids contained in large bacterial populations. At 10-4, for example, only PL1, 472 
contained in the dominant E. coli population persists in time, displacing populations 473 
with PL3, despite the stronger selection pressure (due to AbCR). Higher exposure to 474 
antibiotics (cephalosporins) selecting for PL3 should logically favor the maintenance of 475 
PL3. In any case, PL3 persists much more effectively at low segregation levels (such as 476 
10-5 and 10-6). 477 
Plasmids fitness costs, expressed as a reduction in bacterial growth rate, has a relevant 478 
influence on bacterial resistance phenotypes, particularly on the propagation of plasmids 479 
hosted by minority populations. This effect is particularly visible when the plasmid cost 480 
is ≥0.12. For instance, the spread of PL3 (with AbCR) primarily hosted by K. 481 
pneumoniae is strongly reduced beyond a cost of 0.12. Even if the same cost was 482 
imposed by PL1, as is frequently present in the dominant E. coli, the reduction in fitness 483 
is somewhat compensated by intra-specific transfer; however, when the fitness costs is 484 
0.60, the population with PL1 steadily decreases. Although AbFR populations are not 485 
influenced by plasmid fitness costs, many of the AbFR cells are lost because of the 486 
reduced reproductive rate imposed by the cost of plasmid they might contain. 487 
Mutations might compensate the plasmid fitness costs. The mutation frequency should 488 
therefore affect the number of cost-compensated plasmids, particularly of the plasmids 489 
imposing a higher fitness cost. In our model, the effect on plasmid-mediated resistance 490 
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was almost undetectable at the “consensus” mutation frequency (10-8), which might 491 
suggest that this compensation parameter has low epidemiological consequences. Even 492 
at a general mutation frequency of 10-5, the effects on the spread of antibiotic resistance 493 
under our experimental conditions were barely detectable. Of course, there are 494 
hypermutable strains (with a 10-6 or 10-5 mutation rate), and considering that the 495 
frequency of mutations influencing plasmid compensation might reach 10-5 (40), we 496 
cannot reject the possibility of scenarios in which the mutational cost compensation of E. 497 
coli lineages harboring compensated plasmids tends to increase (56). In fact, this might 498 
explain why E. coli isolates harboring plasmids with extended-spectrum β-lactamases 499 
have increased mutation frequencies (57). As proof of this concept, the benefit for cost-500 
compensated strains (and for K. pneumoniae) becomes clear in a hypothetical scenario 501 
containing strains with a 10-3 mutation frequency (37). 502 
Given that increases in general mutation frequency should necessarily influence the 503 
emergence of chromosomal fluoroquinolone-resistance mutations (AbFR), we 504 
combined the effects of the mutation rate on AbFR acquisition and plasmid-cost 505 
compensatory mutation. Our results indicate that, regardless of the mutational frequency 506 
for plasmid cost compensation, the increased survival and population increase of 507 
fluoroquinolone-resistant cells with high mutation rates increase the absolute number of 508 
plasmid-cost compensatory mutants.  509 
In principle, the beneficial effect of plasmid cost compensation on the evolution of 510 
plasmid spread should be proportional to the reduction in fitness imposed by plasmid 511 
carriage. On one hand, our simulation shows that the cost-compensated bacteria surpass 512 
the number of non-compensated bacteria earlier when the cost is high. However, the 513 
number of plasmid cost-compensated E. coli decreases when the cost of carrying the 514 
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plasmid increases, given that the availability of mutants is dependent on the population 515 
size.  516 
Note that the results of this study correspond to a limited number of possible parametric 517 
landscapes; however, our intention was to use the parameters that frequently influence 518 
plasmid and bacterial dissemination in hospital settings. In any case, a major advantage 519 
of the membrane computing modeling technology is its scalability, allowing to include 520 
many different parametric values simultaneously in the model at the various hierarchical 521 
levels considered in particular ecosystems in workload and scope.  How changes in a 522 
“piece” (the plasmid) contributes to create a particular “pattern” in a nested system of 523 
biological units, expanding from the genes and cells to the communities of human hosts 524 
and environments, is certainly one of the challenges of modern research on antibiotic 525 
resistance (6, 58, 59).  526 
 527 
Materials and Methods 528 
Computing model.  529 
All computational simulations were performed using an updated version of the 530 
Antibiotic Resistance Evolution Simulator (ARES), which is a P system software 531 
implementation for modeling antibiotic resistance evolution (11, 13). The current 532 
version of ARES (2.0) can be freely downloaded at https://sourceforge.net/projects/ares-533 
simulator/. The original ARES website http://gydb.uv.es/ares, offers information on the 534 
rules and parameters currently used by ARES and facilitates customer generation of 535 
specific scenarios to model the evolution of antibiotic resistance.  536 
The basic model application: quantitative structure.  537 
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A detailed account of the main features of our model’s quantitative structure is available 538 
in our previous publication (12), a summary of which is presented below. 539 
Hospitalized hosts, admissions, and discharge rates in the population. The number 540 
of hosts in the hospital reflects an optimal proportion of 10 hospital beds per 1000 541 
individuals in the community (https://data.oecd.org/healtheqt/hospital-beds.htm). The 542 
hospital has 100 occupied beds and corresponds to a population of 10,000 individuals in 543 
the community. The admission and discharge rates from hospital are equivalent to 3–10 544 
individuals/10,000 population/day (http://www.cdc.gov/nchs/data/nhds/1general/). In 545 
the basic model, 6 individuals from the community are admitted to the hospital and 6 546 
are discharged from the hospital to the community per day (approximately at 4 hour-547 
intervals). Approximately 75% of the patients stay in the hospital between 6 and 9 days. 548 
Transfer of bacterial organisms between hospitalized hosts. We used a “contagion 549 
index” of 5% (for every 100 hospitalized patients, 5 “donors” transmit bacteria to 550 
another 5 “recipients” per hour. Bacterial transmission includes the spread of normal 551 
microbiota. The hospital is surrounded by a community of healthy individuals, 552 
occasionally admitted to the hospital, with a “contagion index” of 0.01%.  553 
Exposure to antibiotic agents. We considered 3 types of commonly used antibiotics to 554 
be employed during a 7-day treatment: aminopenicillins (AbA), third-generation 555 
cephalosporins, as cefotaxime (AbC), and fluoroquinolones (AbF). In the basic model, 556 
20% of the individuals in the hospital compartment are under antibiotic exposure each 557 
day. Antibiotics AbA-AbC-AbF are employed in the hospital at a proportion 558 
(percentage) of 30-40-30, respectively. A single patient is treated with only one 559 
antibiotic, administered every 8 hours. After each dose is administered, all 3 560 
(bactericidal) antibiotics induce after a decrease of 30% in the susceptible population 561 
after the first hour of dose exposure, and a 15% reduction in the second hour. In the 562 
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community surrounding the hospital, 1.3% of individuals are undergoing antibiotic 563 
therapy; AbA-AbC-AbF is employed at a proportion of 75-5-20, respectively. 564 
The bacterial colonization space of the populations of the considered clinical species 565 
(E. coli, K. pneumoniae, Pseudomonas aeruginosa, Enterococcus faecium) and other 566 
basic colonic microbiota populations is defined as the volume they occupy in the 567 
intestine. In natural conditions, the sum of these populations is estimated at 108 cells per 568 
mL of colonic content. Clinical species constitute only 1% of the cells in each mL and 569 
have a basal colonization space of 1% of each mL of colonic content (or 0.01 mL). 570 
Other microbiota populations are considered a single ensemble. The colonic space 571 
occupied by these populations can change due to antibiotic exposure. AbA, AbC, and 572 
AbF reduce the intestinal microbiota 25%, 20%, and 10%, respectively. This space can 573 
be occupied by resistant populations of these human opportunistic pathogens; however, 574 
in the absence of antibiotic exposure, the colonic populations tend to return to the basal 575 
population size, which would occur in 2 months (60, 61). 576 
Populations’ operative packages and counts. To facilitate the execution of the model, 577 
we considered that 108 cells in nature is equivalent to 106 cells in the model. In other 578 
words, one “hecto-cell” (h-cell) in the model is an “operative package” of 100 cells in 579 
the real world. Given the high effective population sizes in bacteria, these 100 cells are 580 
considered a uniform population of a single cell type. For computational efficiency, we 581 
considered that each patient (in the hospital) or individual (in the community) is 582 
represented in the model by 1 mL of its colonized colonic space (approximately 3000 583 
mL) and is referred to as a “host-mL”. Our results as therefore represented as “number 584 
of h-cells in all host-mLs" in most of the figures. 585 
Quantitative distribution of species and clones. In the basal scenario, the species 586 
distribution in these 1,000,000 cells (contained in 1 ml) was as follows: for E. coli, 587 
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860,000 cells, including 500,000 susceptible cells, 250,000 containing PL1-AbAR, 588 
100,000 with the AbFR mutation, and 10,000 with the AbFR mutation and carrying PL1 589 
(AbAR); for E. faecium, 99,500 cells susceptible to both AbA and AbF and 20,000 cells 590 
with chromosomal AbCR, AbFR, and CO1-AbAR (CO for Enterococcus conjugative 591 
element); for K. pneumoniae, 20,000 cells, with chromosomal AbAR and AbFR, also 592 
harboring PL3 (AbCR-AbAR); and P. aeruginosa, 500 cells containing PL3 (AbCR-593 
AbAR) and chromosomal AbAR. At time 0, this distribution was identical in 594 
hospitalized and community patients.  595 
Bacterial multiplication rates. We considered the basal multiplication rate 596 
(corresponding to E. coli 0) to be equal to 1, in which each bacterial cell gives rise to 2 597 
daughter cells every hour. Comparatively, the rates for E. faecium, K. pneumoniae, and 598 
P. aeruginosa were 0.85, 0.9, and 0.15, respectively. In these basic conditions, the 599 
acquisition of a plasmid or other incurs an cost of 0.06, while the acquisition of the 600 
AbFR mutation incurs a cost of 0.01 (1% reduction in growth rate) The number of cell 601 
replications will be limited by the available space (see above). 602 
Plasmids and antibiotic resistance types. For the sake of simplicity, this study 603 
considered 2 plasmids sharing the same partition system and therefore competing for 604 
replication when hosted in the same cell, with either 1) resistance to AbA, A for 605 
aminopenicillins) present in plasmid PL1, primarily hosted in E. coli, or (2) resistance 606 
to antibiotic C plus antibiotic A (AbC, C for third generation cephalosporins), primarily 607 
determined by the plasmid PL3, primarily hosted in K. pneumoniae. Note that some 608 
widely spread plasmids that encode extended-spectrum beta-lactamases (ESBLs) 609 
frequently carry genes for AbA resistance. In addition, mutational events lead to the 610 
emergence of chromosomal fluoroquinolone resistance (AbF, F for fluroquinolones). 611 
Organisms mutate to AbF at the same rate: 1 mutant for every 108 bacterial cells per cell 612 
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division. Note that K. pneumoniae has intrinsic (plasmid-independent) resistance to 613 
AbA. Although it was not analyzed in this study (but is included in the model), a clone 614 
of E. faecium resistant to AbA might transfer this resistance to a susceptible clone at a 615 
rate of 10-4 (62).  616 
Basal plasmid kinetic values. We established a basal set of plasmid kinetic values, 617 
based on reports in the literature (1,2, 19-23). In the simulation, modifications to each 618 
value were applied, maintaining the other values fixed; ultimately, more than one 619 
parameter was modified to ascertain the combined effects. The applied basal plasmid 620 
kinetic values were as follows: a) a plasmid transfer rate of 10-6 per hour; i.e., 1 in 621 
100,000 or 1 million donor-recipient contacts that result in random and reciprocal cell-622 
to-cell E. coli-K. pneumoniae transfer of the plasmid (10-9 from each of them to P. 623 
aeruginosa) every hour; b) a plasmid incompatibility rate of 2 plasmids/cell, indicating 624 
that, in the presence of a third plasmid, one of the three is stochastically removed; c) a 625 
rate of plasmid cost of 0.06; i.e., the bacterial growth rate is decreased by 6% when 626 
harboring plasmids); d) a rate of frequency of mutational plasmid cost compensation of 627 
10-5; i.e., in 1 per 100,000 cells, a mutational event in the plasmid or bacterial genome 628 
decreases the plasmid cost by 50%; e) a rate of mutational events leading to significant 629 
fluoroquinolone resistance of 10-8; and f) a rate of plasmid segregation of 10-5, 630 
indicating that stochastically 1 cell among 100,000 eliminates the plasmid it contains.  631 
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Figure S1.  Simplified graphic schema of the membrane computation model. On the top 838 
panel, two bacterial cells of the same or different species (red and green circles) containing a 839 
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chromosome (black oval, 1), where mutations might occur at variable rates (black X, 2); the 840 
absolute number of these cells might be modified. Inside each cell, different antibiotic resistance 841 
genes (red, green, 3), that might be harbored in plasmids of the same Inc groups (blue circle 842 
crown, 4). Plasmids might compete (incompatibility) inside the cell, eventually leading to the 843 
segregation of one of the replicons; also replicons might be submitted to random loss (X, 4), or 844 
impose a fitness cost to the host cell (5); however, cost-compensatory mutations can reduce this 845 
cost, restoring in part or totally the host-cell replication rate (6). Cells can replicate at different 846 
rates (cylinders of red or green ovals). Plasmids can be transferred between cells at different 847 
conjugation rates (horizontal black line). On the middle panel, each one of the squares with 848 
curved angles correspond to a different human hosts (different colors) where these bacterial 849 
cells are established; the colored ovals inside each host correspond (in a simplified way) to the 850 
different species in the microbiota. Bacteria harboring plasmids with resistance genes can be 851 
transferred from human to human hosts at variable rates (for instance, influenced by hospital 852 
hygiene or cross infection). Submitted to antibiotic exposure, different antibiotics can kill 853 
(eliminate) bacterial cells at certain rates, but bacteria might survive is they have resistance 854 
genes; note that other bacteria of the microbiota can also be eliminated by antibiotics, eventually 855 
increasing the population size of the surviving resistant bacteria (as the green cylinders down 856 
right), which can be transferred to new hosts. In the lower panel it is depicted that all these 857 
processes can occur inside a hospital (red square), or in the human community where the 858 
hospital is located (blue square); these compartments are linked by variable admission and 859 
discharge rates (horizontal grey arrows) that can also be introduced in the model; finally, the 860 
bacterial composition inside the human community is influenced by the interaction with the 861 
environment (green square). This figure reveals the multi-nested structure of units involved in 862 
antibiotic resistance.  863 
 864 
 865 
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